4th Quarter - Report

THE MCMANUS GROUP for ALLERGAN INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Support for H.R. 436, Health Care Cost Reduction Act of 2012, and S.17, Medical Device Access and Innovation Protection Act.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
NICK SHIPLEY Legislative Director, Rep. Jay Inslee

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 17 (112th), H.R. 436 (112th)

Health Issues HCR

FDA approval and enforcement issues. Cosmetic safety issues.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
NICK SHIPLEY Legislative Director, Rep. Jay Inslee

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.